These UPMC Children’s Hospital of Pittsburgh staff members recently received recognition in their fields.
In August, Taylor Abel, MD, pediatric neurosurgeon and chief of pediatric epilepsy surgery at UPMC Children’s Hospital of Pittsburgh was named a winner of UPMC’s Excellence in Patient Experience Award. Dr. Abel was selected as a ‘Top UPMC Physician by Specialty,’ in pediatric neurosurgery. According to UPMC, of the more than 5,000 UPMC physicians, Dr. Abel was among only 48 recipients of this award across all of UPMC’s specialties.
In June, Silva Arslanian, MD, director of the Pediatric Clinical and Translational Research Center (PCTRC) and scientific director of the Center for Pediatric Research in Obesity and Metabolism (CPROM) at UPMC Children’s, was awarded the American Diabetes Association’s (ADA) 2023 Outstanding Achievement in Clinical Diabetes Research Award at the ADA’s Annual Scientific Meeting in San Diego, California. The award recognizes Dr. Arslanian’s exceptional contributions towards patient-oriented clinical research that have had a significant impact on diabetes prevention and treatment. Her research has recently been published in The New England Journal of Medicine on the role of semiglutinide in adolescents and on clinical guidelines for treating obesity in children. Dr. Arslanian is the first woman to receive this award, which is highly competitive and rarely awarded to pediatricians.
Christine E. Bishop, MD, MA, director of Perinatal Supportive Care at UPMC Children’s, recently received the Advancing Women in Pediatric Medicine and Science award during the September 21st “Women In Medicine: Voices of Women” Pediatric Grand Rounds series. Dr. Bishop is the first recipient of this new award that was created to recognize a Department of Pediatrics faculty member who demonstrates exceptional dedication to issues that affect women in pediatric medicine within the University of Pittsburgh School of Medicine Department of Pediatrics.
In August, Jessica D. Daley, MD, physician-researcher in pediatric hematology and oncology at UPMC Children’s, was awarded a Young Investigator Award from Alex’s Lemonade Stand Foundation (ALSF) for her research project titled, “Radiation and the Tumor Microenvironment in an Immunocompetent Model of Ewing Sarcoma.” The Award is designed to support the ongoing need for startup funds for less experienced researchers pursuing promising clinical and scientific endeavors. Daley plans on investigating how radiation modulates immune suppression within the tumor with the goal of identifying new ways to improve the efficacy of radiation in the treatment of Ewing sarcoma tumors.
Erika Friehling, MD, and Diego Chaves-Gnecco, MD, MPH, FAAP, recently received the 2023 Castle Connolly Top Hispanic and Latino Doctors award. This award is designed to honor top clinicians and enable patients to find Castle Connolly Top Doctors who have shared backgrounds and experiences. All Castle Connolly Top Hispanic and Latino doctors are nominated by their peers and evaluated by the Castle Connolly research team who determine what doctors make the list.
Amy Houtrow, MD, PhD, MPH, chief of the Division of Pediatric Rehabilitation Medicine at UPMC Children’s, was named to the Board of Scientific Counselors of the NIH Clinical Center for a 2023-2027 term.
Jacqueline Kreutzer, MD, FACC, FSCAI, FPICS, chief of Pediatric Cardiology and co-director of the Heart Institute at UPMC Children’s, received the 2023 Women in Cardiology Mentoring Award from the American Heart Association’s Council on Clinical Cardiology. This prestigious award recognizes individuals who have an outstanding record of effectively mentoring women cardiologists and underscores the importance of mentoring in the professional development of women. Dr. Kreutzer will be presented the award at the 2023 American Heart Association Scientific Sessions which is being held November 11-13 in Philadelphia, Pa.
Christine March, MD, MS, pediatric endocrinologist at UPMC Children's, was awarded a four-year, NIH – NIDDK K23 mentored career development grant for her study titled "School-Partnered Collaborative Care (SPACE) for Pediatric Type 1 Diabetes." Dr. March’s research aims to develop and test a team-based intervention in the school setting to support the health and well-being of children with type 1 diabetes.
In August, Jennifer Marin, MD, MSc, participated in the 75th Anniversary of Pediatrics commentary, “Advancing the Quality of Pediatric Emergency Medicine in Pediatrics.” Robert Hickey, MD, FAAP, FAHA, and Alejandro Hoberman, MD, were also featured authors in the commentary by the American Academy of Pediatrics (AAP). The article was published by the Section of Emergency Medicine (SOEM) within the AAP, one of AAP’s largest sections. This section provides a forum for advocacy, education, and research on patient care in pediatric emergency medicine.
A multidisciplinary team of physician-scientists from UPMC Children’s Hospital of Pittsburgh collaborated on a study of chronic Epstein-Barr virus (EBV) to help improve risk stratification and clinical management of liver, kidney, and heart transplant recipients affected by the virus.
Authors of the analysis, “Distinct association between chronic Epstein-Barr virus infection and T cell compartments from pediatric heart, kidney, and liver transplant recipients,” include George V. Mazariegos, MD, chief, Pediatric Transplantation; Marian G. Michaels, MD, co-director, Transplant Infectious Diseases; and Brian Feingold, MD, medical director, Heart Failure and Transplantation Programs at UPMC Children’s.
Onome Oghifobibi, MD, MSc, FAAP, neonatologist at UPMC Children’s was recently unanimously elected to the Healthy Start Board of Directors. Healthy Start is an organization dedicated to supporting women, children, fathers, families, and communities in Allegheny and Westmoreland counties through comprehensive community-based programming, systems coordination, advocacy, and research and training. As part of a network of more than 100 community-based Healthy Start projects across the country, the organization aims to provide access to affordable and quality maternal and child health care. Dr. Oghifobibi has worked intimately with the resuscitation experts at the Safar Center for Resuscitation Research, focusing on defining the mechanisms underpinning cerebral blood flow dysregulation after asphyxia cardiac arrest with the goal of developing therapeutic strategies to improve neurological outcomes in infants and children with hypoxic-ischemic encephalopathy. He completed his residency in pediatrics at UPMC Children’s Hospital of Pittsburgh, and his medical training at the University of Benin, Nigeria.
In September, Udai Pandey, PhD, director of the Children's Neuroscience Institute, was awarded an R01 grant from the NIH for his project, “Investigating the Contribution of ALS/FTD-Associated Mutations in the NEK1 Kinase to Disease Pathophysiology”. This R01 is a multi-PI R01, in partnership with Evangelos Kiskinis from Northwestern University, that spans over 5 years. The team hopes to shed light into the cellular mechanisms that are compromised by mutant NEK1 in neurons. Their studies will also likely uncover potential therapeutic targets for a significant percentage of ALS/FTD patients.
Then in October, Dr. Pandey’s lab published an article in Nucleic Acids Research titled, “Drosha-dependent microRNAs modulate FUS-mediated neurodegeneration in vivo” and received another R01 grant award for their project “Identifying the molecular mechanisms of GEMIN5 mutations in a novel cerebellar ataxia syndrome.”
Edward V. Prochownik, MD, PhD, director of Oncology Research at UPMC Children’s, had the study he led entitled, “Premature aging and reduced cancer incidence associated with near-complete body-wide Myc inactivation,” published recently in Cell Reports. In it, Dr. Prochownik and others discovered an interesting relationship between Myc inactivation and aging in mouse models. Specifically, their work showed that in mice with functioning Myc proto-oncogenes, remain comparatively healthier and longer-lived than mice with body-wide Myc inactivation initiated postnatally.
Vikram Raghu, MD, MS, associate program director of the Pediatric Gastroenterology Fellowship Program at UPMC Children’s, recently received a one-year research grant from the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition (NASPGHAN) Foundation. This award will allow Dr. Raghu to expand his recruitment efforts in collecting health utility data in pediatric intestinal failure and transplant. The goal is to help determine the effects different interventions have on patients in both length and ongoing quality of life. Dr. Raghu also aims to specifically support translation services for his qualitative work to better understand the unique needs of the Latinx population, given that many families come from Puerto Rico and elsewhere for intestine transplant evaluation.
Kristin N. Ray, MD, MS, FAAP, director of the General Academic Pediatrics Research Fellowship at UPMC Children’s and director of Health Systems Improvement for UPMC Children’s Community Pediatrics, was among three University of Pittsburgh faculty to represent the university at the Executive Leadership in Academic Medicine (ELAM) and Executive Leadership in Health Care (ELH) fall session that took place in Philadelphia from September 9-15. ELAM and ELH were designed for women who aspire to lead at the executive level in the next five years to help enable these women to bring out their full potential in their work.
Kelsey Schweiberger, MD, MS, pediatrician in General Academic Pediatrics at UPMC Children’s was recently recognized as one of the Academy of Communication in Healthcare (ACH) 2023 Putnam Scholars. The Putnam Scholars Program is a two-year fellowship. The Putnam Scholars program is a competitive two-year fellowship that includes retreats, conferences, and support for research. At the end of their fellowship time, Putnam scholars will present the findings of their proposed research at the 2025 International Conference on Communication in Healthcare. Part of the program also includes senior mentorship, networking events, and support for travel and accommodations.
Dr. Schweiberger’s project is designed to utilize qualitative methodologies to understand the ideal inter-visit healthcare communication using the pediatric portal from the perspectives of caregivers and clinicians. Ultimately, this work will help better illuminate the changes in the healthcare communication landscape following the introduction of the patient portal, as well as in how parents choose from the myriad of ways to communicate with their child’s healthcare team. Dr. Schweiberger will work with Judy Chang, MD, MPH, as her senior mentor. Chang is an Associate Professor in both the Department of Obstetrics, Gynecology, and Reproductive Sciences, and the Clinical and Translational Science Institute (CTSI).
In July, Nader Shaikh, MD, MPH, physician-scientist in General Academic Pediatrics (GAP) at UPMC Children’s, had an article published in JAMA Pediatrics, titled, “Short-Course Therapy for Urinary Tract Infections in Children: The SCOUT Randomized Clinical Trial.” In this research project, Shaikh et al., looked at two different treatment protocols for urinary tract infections (UTIs) in children who were afebrile and asymptomatic by day 5 of therapy: a short-course (5 days of placebo after 5 days of antibiotic therapy) vs. standard-course (5 additional days of antibiotic therapy, a total of 10 days). In adults, typical therapy lasts 3-7 days which has long been the standard of care for UTIs, but there has been a significant lack of research into the necessity for extended therapy in children. Dr. Shaikh also has an article published in the Journal of the American Medical Association, titled, “Identifying Children Likely to Benefit From Antibiotics for Acute Sinusitis: A Randomized Clinical Trial.” In this publication, Nader, et al. investigated whether the efficiency of antibiotic treatments differs in children aged 2-11 years with acute sinusitis based on nasopharyngeal colonization with a bacterial pathogen or by the color of the nasal discharge.
In Late August, Eleanor Sharp, MD, MS, associate program director for the Pediatric Hospital Medicine Fellowship at UPMC Children's, was published in Hospital Pediatrics with her article “Frequency, Characteristics, and Outcomes of Patients Requiring Early PICU Readmission”. Also featured on this project from the Department was Catherine Forster, MD, MS, FAAP, who served as Sharp’s mentor on this project. Dr. Sharp and team found that while early PICU readmissions within the same hospitalization are uncommon, they are associated with significantly worse clinical outcomes and patients with medical complexities and technology dependence are especially vulnerable to these outcomes.
To increase awareness of genetic cholestatic liver diseases in the medical community, researchers from UPMC Children’s Hospital of Pittsburgh, including James. E. Squires, MD, MS, clinical lead, Starzl Network for Excellence in Liver Transplantation, and Maria Amendola, MD, published an overview of pediatric primary genetic cholestasis that is not related to biliary atresia, which encompasses between 25% and 50% of cases. The review, titled “Pediatric Genetic Cholestatic Liver Disease Overview” and published in the National Library of Medicine, details clinical characteristics, diagnosis, evaluation strategies, genetic counseling, and management.
In July, Kathryn S. Torok, MD, director of the Pediatric Scleroderma Clinic at UPMC Children’s, had an article published in the International Journal of Molecular Sciences titled, “Single-Cell Transcriptome Analysis Identifies Subclusters with Inflammatory Fibroblast Responses in Localized Scleroderma.” In this research, Dr. Torok and her team employed the use of single-cell RNA sequencing technology, which provides a novel way to assess information at the individual cellular-level, overcoming the inherent similarities shared by localized scleroderma and systemic scleroderma. Then in August, Dr. Torok and her team had an article published in Pediatric Rheumatology titled, “Barriers to Care in Juvenile Localized and Systemic Scleroderma: An Exploratory Survey Study of Caregivers’ Perspectives.” This cross-sectional study gathered caregivers of juvenile localized scleraderma or systemic scleroderma patients to answer surveys regarding child’s condition and their experience in receiving a diagnosis and treatment. Then again in October, Dr. Torok along with Kaila L. Schollaert-Fitch, MS, were published in in the Journal of Investigative Dermatology. Their joint publication, which includes collaborators from the University of Texas Southwestern Medical Center, is titled, “Clinical Characteristics Associated with Musculoskeletal Extracutaneous Manifestations in Pediatric and Adult Morphea: A Prospective, Cohort Study.” This research is specifically focused on Morphea and its related effects on pediatric and adult populations.